1. Home
  2. IMVT vs LEVI Comparison

IMVT vs LEVI Comparison

Compare IMVT & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunovant Inc.

IMVT

Immunovant Inc.

SELL

Current Price

$28.12

Market Cap

8.5B

Sector

Health Care

ML Signal

SELL

Logo Levi Strauss & Co

LEVI

Levi Strauss & Co

HOLD

Current Price

$21.84

Market Cap

8.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMVT
LEVI
Founded
2018
1853
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
8.1B
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
IMVT
LEVI
Price
$28.12
$21.84
Analyst Decision
Buy
Buy
Analyst Count
17
14
Target Price
★ $48.88
$26.79
AVG Volume (30 Days)
1.3M
★ 4.5M
Earning Date
11-09-2026
10-07-2026
Dividend Yield
N/A
★ 3.03%
EPS Growth
N/A
★ 178.85
EPS
N/A
★ 1.10
Revenue
N/A
★ $6,282,000,000.00
Revenue This Year
N/A
$7.26
Revenue Next Year
N/A
$4.59
P/E Ratio
★ N/A
$19.29
Revenue Growth
★ N/A
N/A
52 Week Low
$21.05
$17.72
52 Week High
$45.42
$25.70

Technical Indicators

Market Signals
Indicator
IMVT
LEVI
Relative Strength Index (RSI) 30.46 65.70
Support Level $25.83 $20.60
Resistance Level $29.83 $23.56
Average True Range (ATR) 1.15 0.63
MACD 0.19 0.27
Stochastic Oscillator 28.03 99.42

Price Performance

Historical Comparison
IMVT
LEVI

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

About LEVI Levi Strauss & Co

Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.

Share on Social Networks: